Triple-negative (ER, PR, and HER2 negative) breast cancer, having no receptor sensitivity, is the most lethal subtype of breast cancer because of its heterogeneity, aggressiveness, and lack of treatment options. The gene discussed is ERBB2; the disease is breast carcinoma.